Clinical observation of Tianmeng Oral Liquid in treatment of chronic obstructive pulmonary disease and insomnia / 中草药

ABSTRACT

Objective To observe the clinical effect of Tianmeng Oral Liquid in the treatment of chronic obstructive pulmonary disease and insomnia. Methods Patients (86 cases) with chronic obstructive pulmonary disease and insomnia from February 2013 to February 2015 were randomly divided into control group (43 cases) and experimental group (43 cases). The patients in the control group were administered with conventional therapy. The patients in the treatment group were treated with Tianmeng Oral Liquid on the basis of the control group. Each group was treated for 4 weeks. After treatment, the clinical efficacies and the quality of life were evaluated, and the changes of PSQI scores, total sleep time, sleep efficiency, sleep latency, awakening times, awakening total time, and lung function in two groups were compared. Results After treatment, the clinical efficacies were 79.07% and 93.02% in the control groups and experimental group, respectively, and there were differences between two groups (P < 0.01). After treatment, PSQI scores, awakening times, awakening total time, and respiratory symptoms were significantly reduced, and total sleep time, sleep efficiency, FEV1, and FEV1/FVC were significantly increased, and the difference was significant statistically (P < 0.05). And observational indexes in the experimental group were significantly better than those in the control group (P < 0.05). Conclusion Tianmeng Oral Liquid can improve the sleep quality of patients with the chronic obstructive pulmonary disease and insomnia, also can reduce PSQI scores, which has a certain clinical value.